-
1
-
-
0028906295
-
Issues remain for treating colorectal cancer
-
Reynolds T. Issues remain for treating colorectal cancer. J Natl Cancer Inst 1995;87:480-1.
-
(1995)
J Natl Cancer Inst
, vol.87
, pp. 480-481
-
-
Reynolds, T.1
-
2
-
-
84944285022
-
High dose recombinant interleukin-2 in the treatment of patients with disseminated cancer: Responses, treatment related morbidity and histologic findings
-
Lotze MT, Chang AE, Seipp CA, Simpson C, Vetto JT, Rosenberg SA. High dose recombinant interleukin-2 in the treatment of patients with disseminated cancer: Responses, treatment related morbidity and histologic findings. JAMA 1986;256:3117-24.
-
(1986)
JAMA
, vol.256
, pp. 3117-3124
-
-
Lotze, M.T.1
Chang, A.E.2
Seipp, C.A.3
Simpson, C.4
Vetto, J.T.5
Rosenberg, S.A.6
-
3
-
-
0024166189
-
Immunotherapy of patients with metastatic melanoma using tumour infiltrating lymphocytes and interleukin-2
-
Rosenberg SA, Packard B, Aebersold PM et al. Immunotherapy of patients with metastatic melanoma using tumour infiltrating lymphocytes and interleukin-2. N Engl J Med 1988;319:1676-80.
-
(1988)
N Engl J Med
, vol.319
, pp. 1676-1680
-
-
Rosenberg, S.A.1
Packard, B.2
Aebersold, P.M.3
-
4
-
-
0027298794
-
Strong HLA-DR expression in large bowel carcinomas is associated with good prognosis
-
Andersen SN, Rogum TO, Lund, E, Meling GGI, Hauge S. Strong HLA-DR expression in large bowel carcinomas is associated with good prognosis. Br J Cancer 1993;68:80-5.
-
(1993)
Br J Cancer
, vol.68
, pp. 80-85
-
-
Andersen, S.N.1
Rogum, T.O.2
Lund, E.3
Meling, G.G.I.4
Hauge, S.5
-
5
-
-
0027442201
-
Characterization of the inflammatory cell populations in normal colon and colonic carcinomas
-
Banner BF, Savas L, Baker S, Woda, BA. Characterization of the inflammatory cell populations in normal colon and colonic carcinomas. Virchows Archiv 1993;64:213-20.
-
(1993)
Virchows Archiv
, vol.64
, pp. 213-220
-
-
Banner, B.F.1
Savas, L.2
Baker, S.3
Woda, B.A.4
-
6
-
-
0027597626
-
An immunophenotypic study of the inflammatory cell populations in colon adenomas and carcinomas
-
Banner SF, Samez-Alpna, E, Yousem SA. An immunophenotypic study of the inflammatory cell populations in colon adenomas and carcinomas. Modern Pathol 1993;6:295-301.
-
(1993)
Modern Pathol
, vol.6
, pp. 295-301
-
-
Banner, S.F.1
Samez-Alpna, E.2
Yousem, S.A.3
-
7
-
-
0026651948
-
Expression of class II major histocompatibility complex molecules correlates with human colon-tumour - Vaccine efficay
-
Ransom JH, Pelle B, Hanna Jr MG. Expression of class II major histocompatibility complex molecules correlates with human colon-tumour - vaccine efficay. Cancer Res. 1992;52:3460-6.
-
(1992)
Cancer Res.
, vol.52
, pp. 3460-3466
-
-
Ransom, J.H.1
Pelle, B.2
Hanna Jr., M.G.3
-
8
-
-
0027485675
-
Natural history of HLA-expression during tumour development
-
Garrido FT, Cabrera A, Concha S, Glew F, Ruiz-Cabello F, Stern PL. Natural history of HLA-expression during tumour development. Immunol Today 1993;14:491-9.
-
(1993)
Immunol Today
, vol.14
, pp. 491-499
-
-
Garrido, F.T.1
Cabrera, A.2
Concha, S.3
Glew, F.4
Ruiz-Cabello, F.5
Stern, P.L.6
-
9
-
-
0028345061
-
Human colorectal tumour infiltrating lymphocytes express activation markers and the CD45 RO molecule showing a primed population of lymphocytes in the tumour area
-
Ostenstad B, Schlichting LT, Harboe M. Human colorectal tumour infiltrating lymphocytes express activation markers and the CD45 RO molecule showing a primed population of lymphocytes in the tumour area. Gut 1994;35:382-7.
-
(1994)
Gut
, vol.35
, pp. 382-387
-
-
Ostenstad, B.1
Schlichting, L.T.2
Harboe, M.3
-
10
-
-
0028358357
-
Limited heterogeity in the T-cell receptor V-gene usage in lymphocytes infiltrating human colorectal tumours
-
Ostenstad B, Sioud M, Schlichting LT, Harboe M. Limited heterogeity in the T-cell receptor V-gene usage in lymphocytes infiltrating human colorectal tumours. Br J Cancer 1993;69:1078-82.
-
(1993)
Br J Cancer
, vol.69
, pp. 1078-1082
-
-
Ostenstad, B.1
Sioud, M.2
Schlichting, L.T.3
Harboe, M.4
-
11
-
-
0027512782
-
Adjuvant active specific immunotherapy for human colorectal cancer - 6.5.year median follow-up of a phase-III prospectively randomized trial
-
Hoover Jr. HC, Brandhorst JS, Peters LC et al. Adjuvant active specific immunotherapy for human colorectal cancer - 6.5.year median follow-up of a phase-III prospectively randomized trial. J Clin Oncol 1993;11:390-9.
-
(1993)
J Clin Oncol
, vol.11
, pp. 390-399
-
-
Hoover Jr., H.C.1
Brandhorst, J.S.2
Peters, L.C.3
-
12
-
-
0021259223
-
Delayed cutaneous hypernsensivity to autologous tumour cells n colorectal cancer patients immunized with an autologous tumour cell Bacillus Calmette-Guerin vaccine
-
Hoover Jr HC, Surdyke MG, Dangel RB, Peters LC, Hanna Jr M. Delayed cutaneous hypernsensivity to autologous tumour cells n colorectal cancer patients immunized with an autologous tumour cell Bacillus Calmette-Guerin vaccine. Cancer Res. 1984;44:1671-76.
-
(1984)
Cancer Res.
, vol.44
, pp. 1671-1676
-
-
Hoover Jr., H.C.1
Surdyke, M.G.2
Dangel, R.B.3
Peters, L.C.4
Hanna Jr., M.5
-
13
-
-
0027182433
-
Identification of colon-tumour associated antigens by T-cell lines derived from tumour infiltrating lymphocytes and peripheral-blood lymphocytes from patients immunized with an autologous tumour-cell/Bacillus Calmette-Guerin vaccine. 1993
-
Ransom JH, Pelle BA, Hubers H, Keynton LM, Hanna Jr M, Pomato N. Identification of colon-tumour associated antigens by T-cell lines derived from tumour infiltrating lymphocytes and peripheral-blood lymphocytes from patients immunized with an autologous tumour-cell/Bacillus Calmette-Guerin vaccine. 1993. Int J Cancer 1993;54: 734-40.
-
(1993)
Int J Cancer
, vol.54
, pp. 734-740
-
-
Ransom, J.H.1
Pelle, B.A.2
Hubers, H.3
Keynton, L.M.4
Hanna Jr., M.5
Pomato, N.6
-
14
-
-
0028057702
-
p21-ras-, peptide-specific T-cell responses in a patient with colorectal cancer. CD4+ and CD8+ T cells recognize a peptide corresponding to a common mutation. (13Gly > Aps)
-
Fossum B T, Gedde-Dahl II J, Breivik JA et al. p21-ras-, peptide-specific T-cell responses in a patient with colorectal cancer. CD4+ and CD8+ T cells recognize a peptide corresponding to a common mutation. (13Gly > Aps). Intern J Cancer 1994;56:40-5.
-
(1994)
Intern J Cancer
, vol.56
, pp. 40-45
-
-
Fossum, B.T.1
Gedde-Dahl II, J.2
Breivik, J.A.3
-
15
-
-
0026695836
-
T-cell responses against products of oncogenes: Generation and characterization of human T-cell clones specific for p21 ras- derived synthetic peptides
-
Geede-Dahl II T, Spurkland A, Erikson JA, Thorsby E, Gaudernack G. T-cell responses against products of oncogenes: generation and characterization of human T-cell clones specific for p21 ras- derived synthetic peptides. Hum Immunol 1992;33:266-72.
-
(1992)
Hum Immunol
, vol.33
, pp. 266-272
-
-
Geede-Dahl II, T.1
Spurkland, A.2
Erikson, J.A.3
Thorsby, E.4
Gaudernack, G.5
-
16
-
-
0026074766
-
Human T lymphocytes recognize a peptide of single point-mutated oncogenic ras protein
-
Jung S, Schleusner HJ. Human T lymphocytes recognize a peptide of single point-mutated oncogenic ras protein. J Exp Med 1991;173: 273-79.
-
(1991)
J Exp Med
, vol.173
, pp. 273-279
-
-
Jung, S.1
Schleusner, H.J.2
-
17
-
-
0027234997
-
Specific immune recognition of autologous tumour by lymphocytes infiltrating coloncarcinomas: Analysis by cytokine secretion
-
Hom SA, Rosenberg SA, Topalian SL. Specific immune recognition of autologous tumour by lymphocytes infiltrating coloncarcinomas: analysis by cytokine secretion. Cancer Immunol Immunother 1993; 36:1-8.
-
(1993)
Cancer Immunol Immunother
, vol.36
, pp. 1-8
-
-
Hom, S.A.1
Rosenberg, S.A.2
Topalian, S.L.3
-
18
-
-
0028273754
-
Thymus independent T cell development and selection in the intestinal epithelium
-
Poussier P, Julius M. Thymus independent T cell development and selection in the intestinal epithelium. Annu Rev Immunol 1994;12: 521-33.
-
(1994)
Annu Rev Immunol
, vol.12
, pp. 521-533
-
-
Poussier, P.1
Julius, M.2
-
19
-
-
0025966665
-
Heterogeneity of thymic epithelial cells in promoting T-lymphocytes differentiation in vivo
-
Gutierrez JC, Palacios R. Heterogeneity of thymic epithelial cells in promoting T-lymphocytes differentiation in vivo. Proc Natl Acad Sci USA 1991;88:642-6.
-
(1991)
Proc Natl Acad Sci USA
, vol.88
, pp. 642-646
-
-
Gutierrez, J.C.1
Palacios, R.2
-
20
-
-
0025101928
-
Interleukin 7 enhances cytolytic T lymphocyte generation and induces lymphokine activated killer cells from human peripheral blood
-
Alderson MR, Sassenfeld HM, Widmer MB. Interleukin 7 enhances cytolytic T lymphocyte generation and induces lymphokine activated killer cells from human peripheral blood. J Exp Med 1990; 172:577-87.
-
(1990)
J Exp Med
, vol.172
, pp. 577-587
-
-
Alderson, M.R.1
Sassenfeld, H.M.2
Widmer, M.B.3
-
21
-
-
0025896856
-
Interleukin-7 induces cytokine secretion and tumouricidal activity by human peripheral blood monocytes
-
Alderson MR, Tough TW, Ziegler SF, Grabstein KH. Interleukin-7 induces cytokine secretion and tumouricidal activity by human peripheral blood monocytes J Exp Med 1991;173:923-30.
-
(1991)
J Exp Med
, vol.173
, pp. 923-930
-
-
Alderson, M.R.1
Tough, T.W.2
Ziegler, S.F.3
Grabstein, K.H.4
-
22
-
-
0026027238
-
Development of lymphocytes in interleukin 7 transgenic mice
-
Samaridis J, Casorati G, Traunecker A et al. Development of lymphocytes in interleukin 7 transgenic mice. Eur J Immunol 1991;21:453-60.
-
(1991)
Eur J Immunol
, vol.21
, pp. 453-460
-
-
Samaridis, J.1
Casorati, G.2
Traunecker, A.3
-
23
-
-
0026744872
-
Use of T cell growth factors (interleukins 2, 4, 7, 10, and 12) in the evaluation of T cell reactivity to melanoma
-
Lotze MT, Zeh III HJ, Elder EM et al. Use of T cell growth factors (interleukins 2, 4, 7, 10, and 12) in the evaluation of T cell reactivity to melanoma. J Imunother 1992;12:212-17.
-
(1992)
J Imunother
, vol.12
, pp. 212-217
-
-
Lotze, M.T.1
Zeh III, H.J.2
Elder, E.M.3
-
24
-
-
0026059824
-
Interleukin-7 induces human lymphokine activated killer (LAK) cells and is regulated by interleukin-4
-
Stotter H, Custer MC, Bolon ES, Guedez L, Lotze MT. Interleukin-7 induces human lymphokine activated killer (LAK) cells and is regulated by interleukin-4. J Immunol 1991;146:150-64.
-
(1991)
J Immunol
, vol.146
, pp. 150-164
-
-
Stotter, H.1
Custer, M.C.2
Bolon, E.S.3
Guedez, L.4
Lotze, M.T.5
-
25
-
-
0027324005
-
Interleukin 7 is produced by murine and human keratinocytes
-
Heufler C, Topar G, Grasseger A et al. Interleukin 7 is produced by murine and human keratinocytes. J Exp Med 1993;178:1109-14.
-
(1993)
J Exp Med
, vol.178
, pp. 1109-1114
-
-
Heufler, C.1
Topar, G.2
Grasseger, A.3
-
26
-
-
0028301248
-
Interleukin 7 induces preferential expansion of V beta 8.2+CD4-8- and V beta 8.2+CD4+8-murine thymocytes positively selected by class I molecules
-
Vicari A, de Moraes C, Gombert JM et al. Interleukin 7 induces preferential expansion of V beta 8.2+CD4-8- and V beta 8.2+CD4+8-murine thymocytes positively selected by class I molecules. J Exp Med 1994;180:653-61.
-
(1994)
J Exp Med
, vol.180
, pp. 653-661
-
-
Vicari, A.1
De Moraes, C.2
Gombert, J.M.3
-
27
-
-
0027517421
-
Interleukin-7 induced expression of specific T cell receptor gamma variable regions in murine fetal liver cultures
-
Appasamy PM, Kenniston Jr TW, Weng Y, Holt EC, Kost J, Chambers WH. Interleukin-7 induced expression of specific T cell receptor gamma variable regions in murine fetal liver cultures. J Exp Med 1993;178:2201-6.
-
(1993)
J Exp Med
, vol.178
, pp. 2201-2206
-
-
Appasamy, P.M.1
Kenniston Jr., T.W.2
Weng, Y.3
Holt, E.C.4
Kost, J.5
Chambers, W.H.6
-
28
-
-
8044245535
-
Processing of tumours for vaccine and / or tumour infiltrating lymphocytes
-
Rose NR, Conway de Macaio E, Fahey JL, Friedman H, Penn GM (eds.) American Society for Microbiology
-
Elder EM, Whiteside TL. Processing of tumours for vaccine and / or tumour infiltrating lymphocytes. In: Rose NR, Conway de Macaio E, Fahey JL, Friedman H, Penn GM (eds.) Manual of Clinical Laboratory Immunology, 4th ed. American Society for Microbiology, 1992; 817-19.
-
(1992)
Manual of Clinical Laboratory Immunology, 4th Ed.
, pp. 817-819
-
-
Elder, E.M.1
Whiteside, T.L.2
-
29
-
-
0027295529
-
Intercellular interaction and cytokine responsiveness of peritoneal αβ and γδ T cells from listeria-infected mice: Synergistic effects of interleukin 1 and 7 on γδ T cells
-
Skeen MJ, Ziegler HK. Intercellular interaction and cytokine responsiveness of peritoneal αβ and γδ T cells from listeria-infected mice: Synergistic effects of interleukin 1 and 7 on γδ T cells. J Exp Med 1993;178:985-96.
-
(1993)
J Exp Med
, vol.178
, pp. 985-996
-
-
Skeen, M.J.1
Ziegler, H.K.2
-
30
-
-
0027282232
-
Induction of murine peritoneal gamma/delta T cells and their role in bacterial infection
-
Skeen MJ, Ziegler HK. Induction of murine peritoneal gamma/delta T cells and their role in bacterial infection. J Exp Med 1993;178: 971-84.
-
(1993)
J Exp Med
, vol.178
, pp. 971-984
-
-
Skeen, M.J.1
Ziegler, H.K.2
-
31
-
-
0023277545
-
Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
-
Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987;162:156-9.
-
(1987)
Anal Biochem
, vol.162
, pp. 156-159
-
-
Chomczynski, P.1
Sacchi, N.2
-
32
-
-
45349110931
-
The role of cell surface recognition structures in the initiation of MHC-unrestricted 'promiscuous' killing by T cells
-
Thiele DL, Lipsky PE. The role of cell surface recognition structures in the initiation of MHC-unrestricted 'promiscuous' killing by T cells. Immunol Today 1989;10:375-81.
-
(1989)
Immunol Today
, vol.10
, pp. 375-381
-
-
Thiele, D.L.1
Lipsky, P.E.2
-
33
-
-
0020972294
-
Lymhokine driven 'differentiation' of cytotoxic T cell clones into cells with NK like specificity: Correlation with display of membrane macromolecules
-
Books CG, Urdal DL, Henney CS. Lymhokine driven 'differentiation' of cytotoxic T cell clones into cells with NK like specificity: Correlation with display of membrane macromolecules. Immunol Rev 1983;72:43-72.
-
(1983)
Immunol Rev
, vol.72
, pp. 43-72
-
-
Books, C.G.1
Urdal, D.L.2
Henney, C.S.3
-
34
-
-
0024282606
-
Stimulation of B-cell progenitors by cloned murine interleukin-7
-
Namen AE, Lutpon S, Hjerrild K et al. Stimulation of B-cell progenitors by cloned murine interleukin-7. Nature 1988;333: 571-4.
-
(1988)
Nature
, vol.333
, pp. 571-574
-
-
Namen, A.E.1
Lutpon, S.2
Hjerrild, K.3
-
35
-
-
0007401521
-
Human interleukin 7. Molecular cloning and growth Factor activity on human and murine B-lineage cells
-
Goodwill RG, Lupton S, Schmierer A et al. Human interleukin 7. Molecular cloning and growth Factor activity on human and murine B-lineage cells. Proc Natl Acad Sci USA 1989;86:302-7.
-
(1989)
Proc Natl Acad Sci USA
, vol.86
, pp. 302-307
-
-
Goodwill, R.G.1
Lupton, S.2
Schmierer, A.3
-
36
-
-
0028943682
-
IL-7 in the cell mediated immune response to a human pathogen
-
Sieling PA, Sakimura L, Uyemura K et al. IL-7 in the cell mediated immune response to a human pathogen. J Immunol 1995;154: 2775-83.
-
(1995)
J Immunol
, vol.154
, pp. 2775-2783
-
-
Sieling, P.A.1
Sakimura, L.2
Uyemura, K.3
-
37
-
-
0028773479
-
B cell IL-7. Human B cell lines constitutively secrete IL-7 and express IL-7 receptors
-
Benjamin D, Sharma V, Knohloch TJ, Armitage RJ, Dayton MA, Goodwill RG. B cell IL-7. Human B cell lines constitutively secrete IL-7 and express IL-7 receptors. J Immunol 1994;152:4749-57.
-
(1994)
J Immunol
, vol.152
, pp. 4749-4757
-
-
Benjamin, D.1
Sharma, V.2
Knohloch, T.J.3
Armitage, R.J.4
Dayton, M.A.5
Goodwill, R.G.6
-
38
-
-
0028123790
-
A bone marrow stromal-derived growth factor, interleukin-11, stimulates recovery of small intestinal mucosal cells after cytoablative therapy
-
Du XX, Doerschuk CM, Orazi A, Williams DA. A bone marrow stromal-derived growth factor, interleukin-11, stimulates recovery of small intestinal mucosal cells after cytoablative therapy. Blood 1994; 83:33-7.
-
(1994)
Blood
, vol.83
, pp. 33-37
-
-
Du, X.X.1
Doerschuk, C.M.2
Orazi, A.3
Williams, D.A.4
-
39
-
-
0028179054
-
Cloning of a novel T cell growth factor which interacts with theβ chain of the interleukin-2 receptor
-
Grabstein KH, Eisenman J, Shanebeck K et al. Cloning of a novel T cell growth factor which interacts with theβ chain of the interleukin-2 receptor. Science 1994;264:2822-6.
-
(1994)
Science
, vol.264
, pp. 2822-2826
-
-
Grabstein, K.H.1
Eisenman, J.2
Shanebeck, K.3
-
40
-
-
8044229633
-
A less toxic IL-2 analogue? The investigation of interleukin-15
-
Wessell D. A less toxic IL-2 analogue? The investigation of interleukin-15. Cope, Working in Oncology 1995;6-10.
-
(1995)
Cope, Working in Oncology
, pp. 6-10
-
-
Wessell, D.1
-
41
-
-
0027378758
-
Keratinocytes-derived IL-7 serves as a growth factor for dendritic epidermal T cells in mouse skin
-
Matsue H, Bergstresser PR, Takahashima A. Keratinocytes-derived IL-7 serves as a growth factor for dendritic epidermal T cells in mouse skin. J Immunol 1993;151:6012-18.
-
(1993)
J Immunol
, vol.151
, pp. 6012-6018
-
-
Matsue, H.1
Bergstresser, P.R.2
Takahashima, A.3
-
44
-
-
0028287478
-
Serum cytokine levels after small bowel tranplantation (SBT) in pigs. Influence of FK506 treatment
-
Ippoliti G, Piazza P, Spada M et al. Serum cytokine levels after small bowel tranplantation (SBT) in pigs. Influence of FK506 treatment. Transpl Proc 1994;26:1562-3.
-
(1994)
Transpl Proc
, vol.26
, pp. 1562-1563
-
-
Ippoliti, G.1
Piazza, P.2
Spada, M.3
-
45
-
-
0028275670
-
Lysis of allogeneic and autologous melanoma cells by IL-7 induced lymphokine-activated killer cells
-
Bohm M, Moller P, Kalbfleisch U, Worm M, Czaenetzki BM, Schadendorf D. Lysis of allogeneic and autologous melanoma cells by IL-7 induced lymphokine-activated killer cells. Br J Cancer 1994;70:54-9.
-
(1994)
Br J Cancer
, vol.70
, pp. 54-59
-
-
Bohm, M.1
Moller, P.2
Kalbfleisch, U.3
Worm, M.4
Czaenetzki, B.M.5
Schadendorf, D.6
-
46
-
-
0027136087
-
Transduction of human melanoma cell lines with the human interleukin-7 gene using retroviral-mediated gene tranfer: Comparison of immunologic properties with interleukin-2
-
Miller AR, McBride WH, Dubinett SM et al. Transduction of human melanoma cell lines with the human interleukin-7 gene using retroviral-mediated gene tranfer: comparison of immunologic properties with interleukin-2. Blood 1993;82:3683-94.
-
(1993)
Blood
, vol.82
, pp. 3683-3694
-
-
Miller, A.R.1
McBride, W.H.2
Dubinett, S.M.3
-
47
-
-
0027503051
-
Interleukin 7 enhances the proliferation and effector function of tumour-infiltrating lymphocytes from renal cell cancer
-
Sica D, Rayman P, Stanley J et al. Interleukin 7 enhances the proliferation and effector function of tumour-infiltrating lymphocytes from renal cell cancer. Intern J Cancer 1993;53:941-47.
-
(1993)
Intern J Cancer
, vol.53
, pp. 941-947
-
-
Sica, D.1
Rayman, P.2
Stanley, J.3
-
48
-
-
0028297264
-
Interleukin 2-independent interleukin 7 activity enhances cytotoxic immune responses of HIV-1 infected individuals
-
Carini C, Essex M. Interleukin 2-independent interleukin 7 activity enhances cytotoxic immune responses of HIV-1 infected individuals. AIDS Res & Hum Retrovir 1994;10:121-30.
-
(1994)
AIDS Res & Hum Retrovir
, vol.10
, pp. 121-130
-
-
Carini, C.1
Essex, M.2
-
49
-
-
0027494098
-
Use of interleukin-7, interleukin-2 and interferon-gamma to propagate CD4+ T-cells in culture with maintained antigen specificity
-
Cohen PA, Kim H, Fowler DH et al. Use of interleukin-7, interleukin-2 and interferon-gamma to propagate CD4+ T-cells in culture with maintained antigen specificity. J Immunother 1993;14:242-52.
-
(1993)
J Immunother
, vol.14
, pp. 242-252
-
-
Cohen, P.A.1
Kim, H.2
Fowler, D.H.3
-
50
-
-
0028120894
-
Interleukin 7 promotes long-term in vitro growth of anti tumour cytotoxic T lymphocytes with immunotherapeutic efficay in vivo
-
Lynch DE, Miller RE. Interleukin 7 promotes long-term in vitro growth of anti tumour cytotoxic T lymphocytes with immunotherapeutic efficay in vivo. J Exp Med 1994;179:31-42.
-
(1994)
J Exp Med
, vol.179
, pp. 31-42
-
-
Lynch, D.E.1
Miller, R.E.2
-
51
-
-
0028118899
-
Colon adenocarcinoma cells inhibit anti-CD3-activated killler cell induction
-
Hoskin DW, Reynolds T, Blay J. Colon adenocarcinoma cells inhibit anti-CD3-activated killler cell induction. Cancer Immunol Immunother 1994;48:201-7.
-
(1994)
Cancer Immunol Immunother
, vol.48
, pp. 201-207
-
-
Hoskin, D.W.1
Reynolds, T.2
Blay, J.3
-
52
-
-
0027437465
-
Antitumour effects of interleukin-7 and adoptive immunotherapy on human colon carcinoma xenografts
-
Murphy WJ, Back TC, Conlon KC et al. Antitumour effects of interleukin-7 and adoptive immunotherapy on human colon carcinoma xenografts. J Clin Invest 1993;92:1918-24.
-
(1993)
J Clin Invest
, vol.92
, pp. 1918-1924
-
-
Murphy, W.J.1
Back, T.C.2
Conlon, K.C.3
|